NFATC2 and neoplasm: The tumours in the mice inoculated with MRPS16‐OE + NFATC2‐KD U87 cells grew slower than the other two groups, as indicated by the bioluminescence of the tumour (Figure 7C), and the overall survival is higher than these two groups.